Comparison Study of Letrozole Alone or Letrozole With Zoledronic Acid in Early Breast Cancer, Neoadjuvant Therapy
This study is to measure the extent of tumor shrinkage when Letrozole and Zoledronic Acid are given before surgery to newly diagnosed post-menopausal women with early breast cancer
Breast Cancer
DRUG: Zoledronic Acid; Letrozole
Clinical response at 24 weeks
Clinical response at 16 weeks|Clinical benefit at 16 weeks|Clinical benefit at 24 weeks|Rate of breast conserving surgery in both arms|Rate of complete pathological response|Biomarkers
This study is to measure the extent of tumor shrinkage when Letrozole and Zoledronic Acid are given before surgery to newly diagnosed post-menopausal women with early breast cancer